Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference9 articles.
1. Drug-drug interactions (DDIs) in psychiatric practice, part 9: interactions mediated by drug-metabolizing cytochrome P450 enzymes;Preskorn;J Psychiatr Pract,2020
2. Complexities of personalized medicine: how genes, drug-drug interactions, dosing schedules, and other factors can combine to produce clinically meaningful differences in a drug’s effect;Preskorn;J Psychiatr Pract,2013
3. How pharmacogenomics (PG) are changing practice: implications for prescribers, their patients, and the healthcare system (PG series part I);Preskorn;J Psychiatr Pract,2013
4. Understanding outliers on the usual dose-response curve: venlafaxine as a way to phenotype patients in terms of their CYP 2D6 status and why it matters;Preskorn;J Psychiatr Pract,2010
5. Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system;Preskorn;J Psychiatr Pract,2008
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献